14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 7th May 2024 WINT stock ended at $4.40. This is 9.74% less than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 39.50% from a day low at $4.38 to a day high of $6.11.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Windtree Therapeutics Inc prices

Date Open High Low Close Volume
Feb 28, 2022 $1.03 $1.10 $1.03 $1.07 129 706
Feb 25, 2022 $1.04 $1.08 $1.04 $1.06 40 718
Feb 24, 2022 $0.96 $1.04 $0.96 $1.03 78 900
Feb 23, 2022 $1.01 $1.02 $0.99 $1.01 66 383
Feb 22, 2022 $0.99 $1.05 $0.99 $1.01 78 299
Feb 18, 2022 $1.10 $1.10 $1.05 $1.06 66 977
Feb 17, 2022 $1.10 $1.10 $1.05 $1.06 54 718
Feb 16, 2022 $1.05 $1.11 $1.00 $1.10 319 908
Feb 15, 2022 $1.04 $1.06 $1.01 $1.05 102 560
Feb 14, 2022 $1.08 $1.08 $1.01 $1.01 228 069
Feb 11, 2022 $1.14 $1.15 $1.05 $1.09 165 426
Feb 10, 2022 $1.18 $1.21 $1.06 $1.12 140 282
Feb 09, 2022 $1.21 $1.29 $1.18 $1.19 106 760
Feb 08, 2022 $1.26 $1.27 $1.21 $1.22 32 879
Feb 07, 2022 $1.25 $1.32 $1.23 $1.28 73 744
Feb 04, 2022 $1.29 $1.29 $1.23 $1.27 80 114
Feb 03, 2022 $1.20 $1.32 $1.13 $1.27 154 770
Feb 02, 2022 $1.38 $1.38 $1.20 $1.24 194 345
Feb 01, 2022 $1.10 $1.44 $1.06 $1.31 1 057 590
Jan 31, 2022 $1.10 $1.16 $1.10 $1.13 69 744
Jan 28, 2022 $1.06 $1.08 $1.02 $1.06 106 678
Jan 27, 2022 $1.16 $1.21 $1.08 $1.09 145 046
Jan 26, 2022 $1.22 $1.24 $1.15 $1.16 65 298
Jan 25, 2022 $1.15 $1.23 $1.15 $1.18 55 532
Jan 24, 2022 $1.29 $1.30 $1.10 $1.15 304 113
Click to get the best stock tips daily for free!

About Windtree Therapeutics Inc

Windtree Therapeutics Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart failure, as well as in Phase IIa clinical trial for the treatment of early cardiogenic shock; AEROSURF,... WINT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT